AVITA Medical Q3 EPS $(0.34) Down From $(0.22) YoY, Sales $13.64M Beat $13.37M Estimate
Portfolio Pulse from Benzinga Newsdesk
AVITA Medical reported Q3 losses of $(0.34) per share, a 54.55% decrease YoY. However, the company's quarterly sales of $13.64M beat the analyst consensus estimate of $13.37M by 2.08%, marking a 50.08% increase YoY.
November 09, 2023 | 9:50 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
AVITA Medical's Q3 earnings per share decreased by 54.55% YoY, but sales beat estimates and increased by 50.08% YoY.
While AVITA Medical's Q3 earnings per share decreased significantly YoY, the company's sales beat estimates and showed a substantial increase YoY. This mixed result could lead to neutral short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100